A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NA · SINGLE GROUP · TREATMENT · NONE
- Evidence population
- Human clinical study registration
- Participants
- 16
- Population
- ALL · 50 Years to 80 Years
- Duration
- 2025-10-22 to 2026-04-01
- Intervention
- Circadian Rhythm Optimization
- Comparator
- Not reported
- Outcomes measured
- HbA1c (%) — Baseline and 90 days; Grip Strength — Baseline and 90 days; Isometric Knee Strength — Baseline and 90 days; VO2 Max — Baseline and 90 days; Time to 85% of Age Predicted Maximal Heart Rate — Baseline and 90 days; Flanker Inhibitory and Control and Attention Test (Fully-Corrected T-score) — Baseline and 90 days; Dimensional Change Card Sort (Fully-Corrected T-score) — Baseline and 90 days; Pattern Comparison Processing Speed Test (Fully-Corrected T-score) — Baseline and 90 days; Picture Sequence Memory test (Fully-Corrected T-score) — Baseline and 90 days; Trail Making Test — Baseline and 90 days; Glucagon (pg/mL) — Baseline and 90 days; Leptin (ng/mL) — Baseline and 90 days; IL-1α (pg/mL) — Baseline and 90 days; IL-1β (pg/mL) — Baseline and 90 days; IL-2 (pg/mL) — Baseline and 90 days; IL-3 (pg/mL) — Baseline and 90 days; IL-4 (pg/mL) — Baseline and 90 days; IL-5 (pg/mL) — Baseline and 90 days; IL-6 (pg/mL) — Baseline and 90 days; IL-7 (pg/mL) — Baseline and 90 days
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sleep · 100%Title contains controlled term: circadian. Abstract contains controlled term: sleep, circadian. Source terminology contains: circadian. Title supplies longevity context: rejuvenation. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.